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ABSTRACT 
IgG4-related disease is a newly recognized systemic disease characterized by involving a 
wide range of organs. It includes the pancreas, biliary tree, salivary glands, periorbital tissues, 
upper aerodigestive tract, retroperitoneum, mediastinum, aorta, soft tissue, skin, central nerv-
ous system, breast, kidneys, prostate, lungs and lymph nodes. The elevated serum titer of im-
munoglobulin G4 (IgG4), which is the least common (3 % to 6 %) of the 4 subclasses of IgG, 
is a special marker for IgG4-related disease. However, its entity is still unknown. This article 
reviewed the literature to learn the IgG4-related diseases and their current status of diagnostic 
approaches. 
 
Keywords: IgG4-related disease, autoimmune pancreatitis, IgG4-related sclerosing cholangi-
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INTRODUCTION 
IgG4-related disease is a newly recog-
nized fibroinflammatory condition charac-
terized by tumefactive lesions, a dense 
lymphoplasmacytic infiltrate rich in IgG4-
positive plasma cells, storiform fibrosis, 
often but not always elevated serum IgG4 
concentration and a favorable response to 
steroids (Stone et al., 2012). IgG4-related 
disease affects predominantly middle-aged 
and elderly patients, with male predomi-
nance. The patients present with symptoms 
referable to the involvement of one or more 
sites either simultaneously or serially, usu-
ally in the form of mass lesions, including 
the pancreas, biliary tree, salivary glands, 
periorbital tissues, kidneys, lungs and 
lymph nodes. In this review, we will dis-
cuss the new information on autoimmune 
pancreatitis,sclerosing cholangitis, retro-
peritoneal fibrosis and their current diag-
nostic approaches in detail. 
Autoimmune pancreatitis 
Autoimmune pancreatitis (AIP) is a 
unique and rare form of chronic pancreatitis 
(less than 5 % of all chronic pancreatitis). 
While it’s wildly known was increasing 
worldwide. In 1961, Sarles et al. reported 
one case of pancreatitis associated with ob-
structive jaundice and hyperglobulinemia, 
suggestive of an underlying autoimmune 
process (Sarles et al., 1961). Until 1995, 
Yoshida et al. reported the term of ‘Auto-
immune Pancreatitis’, which described a 
diffuse enlargement of the pancreas and ir-
regular narrowing of the pancreatic duct, 
serologically associated with hyperglobu-
linemia or IgG levels, anti-nuclear antibody 
(ANA) positivity and fibrotic change with 
lymphocyte infiltration (Yoshida et al., 
1995). Since then, many AIP cases have 
been reported in Japan and other countries, 
and some researchers have paid attention to 
the AIP. However, its definite pathogenesis 
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remains unclear. Therefore, AIP was once 
named as sclerosing pancreatitis, primary 
inflammatory pancreatitis, lymphoplasma-
cytic sclerosing pancreatitis, autoimmune 
pancreatitis, chronic pancreatitis with dif-
fuse irregular narrowing of the main pan-
creatic duct, and sclerosing pancreatico-
cholangitis et al. In 2001, Hamano et al. 
obtained serum samples from 20 patients 
with sclerosing pancreatitis, and the corre-
sponding contrast group patients, and the 
result showed IgG4 was significantly in-
creased in AIP patients; but the concentra-
tions of IgG1, IgG2, IgG3 or IgA, IgM, or 
IgE had not significantly difference be-
tween autoimmune pancreatitis and normal 
subjects (Hamano et al., 2001). With the 
more cases of AIP were observed, the Japan 
Pancreas Society firstly proposed the diag-
nostic criteria of AIP in 2002 according to 
the serologic findings and imaging (Mem-
bers of the Criteria Committee for Auto-
immune Pancreatitis, 2002). Since then AIP 
diagnostic criteria have undergone several 
changes. In 2006, Mayo Clinic College of 
Medicine summarized the criteria as 
HISORt (Table 1) based on the five cardi-
nal features of AIP in histology, imaging, 
serology, other organ involvement, and re-
sponse to steroid therapy. The third Japan–
Korea symposium on AIP in 2008 obtained 
the consensus and set the final Asian crite-
ria (Table 2). Currently, the criteria summa-
rized as HISTOR and the final Asian crite-
ria are the main criteria for the diagnosis of 
AIP (Chari, 2007; Divatia et al., 2012). At 
the AIP Summit 2008, evaluation of pa-
tients and the pathology of autoimmune 
pancreatitis suggest that AIP should be 
classified into two types. Type 1, the patho-
logical synonym of which is lympho-
plasmacytic sclerosing pancreatitis (LPSP) 
characterized by predominantly lobular in-
volvement with “storiform” fibrosis, oblit-
erative phlebitis, and infiltration by many 
IgG4+ plasma cells, typically seen in older 
males; Type 2, which is identified based on 
the histological features of neutrophilic in-
filtration into the pancreatic duct epithelium 
(granulocytic epithelial lesion: GEL). The 
differences between Type 1 and Type 2 au-
toimmune pancreatitis are listed in Table 3 
(Zen et al., 2011). Type 1, which is very 
similar to pancreatic cancer, is a pancreatic 
manifestation of igG4 related disease. 
While Type 2 represents the main pattern in 
western series, and no association with ex-
trapancreatic involvement has been de-
scribed except for inflammatory bowel dis-
ease (IBD) in 20 %–30 % of the cases (Re-
bours et al., 2012). In 2010, Moon and co-
authors proposed that expression of IgG4 in 
duodenal papillary biopsy specimens may 
be useful for the diagnosis of AIP. In 2012, 
Rebours et al. reported IgG4-positive plas-
ma cells from the major papilla or pancreat-
ic tissue are useful for the diagnosis of AIP. 
While, in other digestive tissues such as 
gastric mucosa and colonic mucosa IgG4-
positive cells were not specific for AIP di-
agnosis, especially in patients with IBD 
(Moon et al., 2010).  
 
IgG4-related sclerosing cholangitis  
IgG4-related disease includes IgG4-
related sclerosing cholangitis (IRSC or 
IgG4-SC), which involves the biliary duct 
and gallbladder. In 1963, Bartholomew et 
al. reported two cases of primary sclerosing 
cholangitis (PSC) with pancreatic involve-
ment in the New England Journal of Medi-
cine. These might have been the first two 
cases of IRSC reported (Bartholomew et 
al., 1963). Since then, it was always named 
by IgG4-related disease or autoimmune 
pancreatitis in literature. The pathogenesis 
of the IgG4-related sclerosing cholangitis 
was still unknown, and therefore it was 
once named by inflammatory pseudotumor 
from sclerosing cholangitis (Jafri et al., 
1983), primary sclerosing cholangitis mim-
icking chronic pancreatitis (Laszik et al., 
1988), pancreatic pseudotumor with multi-
focal idiopathic fibrosclerosis (Clark et al., 
1988), lymphoplasmacytic sclerosing pan-
creatitis with cholangitis (Kawaguchi et al., 
1991), sclerosing pancreato-cholangitis 
(Erkelens et al., 1999), atypical primary 
sclerosing cholangitis associated with unu-
sual pancreatitis (Nakazawa et al., 2001), 
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lymphoplasmacytic sclerosing cholangitis 
without pancreatitis (Nakazawa et al., 
2004), immunoglobulin G4-related lym-
phoplasmacytic sclerosing cholangitis, au-
toimmune pancreatitis-associated sclerosing 
cholangitis. And recently it was named 
IgG4-associated cholangitis (IAC) (Björns-
son et al. 2007). Since 2009, IAC has re-
ceived more attention, owning to its steroid-
responsive nature, which is similar to IgG4-
related disease (Deshpande et al., 2009). 
The followings will discuss the new find-
ings of IAC in recent years. IAC is charac-
terized by obstructive jaundice, coexistence 
of AIP(74–96 %), lymphoplasmacytic infil-
tration and abundant IgG4-positive plasma 
cells, an immune reaction predominantly 
mediated by Th2 cells and Tregs, response 
well to steroid therapy or biliary drainage 
(Nishimori et al., 2009). Indeed, IAC shows 
various cholangiographic features which is 
similar to those of pancreatic cancer (PCa), 
PSC, and cholangiocarcinoma (CC) on 
cholangiography and clinical features. In 
2006, Nakazawa et al. reported that IgG4-
SC can be classified into four types based 
on the region of strictures revealed by chol-
angiography.These types include: Type 1, 
in which stenosis is located only in the low-
er part of the common bile duct; Type 2, in 
which stenosis is diffusely distributed 
throughout the intra- and extrahepatic bile 
ducts; Type 3, in which stenosis is detected 
in both the hilar hepatic region and the low-
er part of the common bile duct; and Type 
4, in which strictures of the bile duct are 
detected only in the hilar hepatic region. 
Cholangiographic findings in Type 1 of our 
classification can often lead to a misdiagno-
sis of pancreatic carcinoma, those in Type 2 
as PSC, and those in Types 3 and 4 as chol-
angiocarcinoma (Nakazawa et al., 2006). 
The comparison of IAC, PSC and CC is 
listed in Table 4. In 2011, Nakazawa et al. 
made diagnostic procedures for IgG4-
related sclerosing cholangitis (Nakazawa et 
al., 2011). In 2012, Nakazawa et al. estab-
lished diagnostic criteria for IgG4-SC based 
on cholangiographic classification (sensitiv-
ity 100 %, specificity 96.3 %) (Nakazawa et 
al., 2012). Diffuse or segmental stenosis of 
bile duct with wall thickening, together 
with one of criteria 1, 2, or 3. 
 
 
 
Table 1: Mayo Clinic diagnostic criteria for autoimmune pancreatitis (IgG4-related sclerosing  
pancreatitis): The HISORt criteria 
Criterion H-Histology  
(at least one of the following)  
1. Periductal lymphoplasmacytic infiltrate, obliterative phlebitis, 
storiform fibrosis 2. Lymphoplasmacytic infiltrate, storiform fibro-
sis, abundant IgG4+ cells (≥10 HPF) 
Criterion I-Imaging of pancreas 1. Typical-diffusely enlarged gland with delayed (rim) enhance-
ment; diffusely irregular, attenuated main pancreatic duct 2. Oth-
ers-Focal pancreatic mass / enlargement; focal pancreatic duct 
stricture; pancreatic atrophy; pancreatic calcification; pancreatitis 
Criterion S-Serology Elevated serum IgG4 (normal: 8-140 mg/dl) 
Criterion O - Other organ 
involvement (can be confirmed 
by biopsy or resolution/ 
improvement with steroid 
therapy) 
Hilar/intrahepatic biliary strictures; persistent distal biliary stric-
ture; parotid/lacrimal gland involvement; mediastinal lymphadeno-
pathy; retroperitoneal fibrosis 
Criterion R-Response to 
steroid therapy 
Resolution or marked improvement of pancreatic/extrapancreatic 
manifestation with steroid therapy 
Diagnostic of autoimmune 
pancreatitis when any of the 
following is fulfilled 
1. Criterion H 2. Criterion I+S 3. Strong clinical suspicion of auto-
immune pancreatitis (idiopathic pancreatic disease + Criterion S 
and/or O) + Criterion R 
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Table 2: Asian diagnostic criteria (Japan-Korea Consensus) for autoimmune pancreatitis 
Criterion I - Imaging (both required) 1. Pancreatic parenchyma-diffuse / segmental / focal en-
largement of the gland, occasionally with a mass and/or hy-
poattenuation rim; 2.Pancreaticobiliary ducts-diffuse / seg-
mental / focal pancreatic duct narrowing, often with stenosis 
of bile duct 
Criterion II - Serology (1 required)   1. High levels of serum IgG or IgG4 2. Detection of autoanti-
bodies 
Criterion III - Histopathology of  
pancreatic biopsy 
Lymphoplasmacytic infiltration with fibrosis and abundant 
IgG4+ cells 
Criterion IV - Histopathology of  
resected pancreas 
Lymphoplasmacytic sclerosing pancreatitis storiform fibrosis, 
lymphoplasmacytic infiltration, periductal inflammation, oblit-
erative phlebitis, numerous IgG4+ cells) 
Optional criterion - Response to 
steroid therapy 
Diagnostic trial of steroid therapy should be conducted only 
in patients fulfilling criterion I alone with negative work-up 
results for pancreatobiliary cancer 
Diagnostic of autoimmune pancrea-
titis when any of the following is 
fulfilled: 
1. Criterion I+II 
2. Criterion I+III 
3. Criterion I+II+III 
4. Criterion IV 
 
Table 3: Comparison of type1 and type2 autoimmune pancreatitis (AIP) 
 Type 1  AIP Type 2  AIP 
Age Adult Child and adult 
Gender predominantly Male     Almost equal 
Serum IgG4 levels    Elevated (usually >10/hpf)   Normal 
Histological nomenclature Lymphoplasmacytic  
sclerosing pancreatitis 
Idiopathic duct-centric  
pancreatitis 
Ducts   Periductal inflammation  
preserved epithelium 
intraepithelial neutrophils  
damaged epithelium 
Lobule    Lymphoplasmacytic inflamma-
tion with storiform fibrosis 
Patchy inflammation, often with 
neutrophils 
Veins    Phlebitis very common Phlebitis unusual 
IgG4+ plasma cells Many Rare 
Granulocytic epithelial lesion Absent Present 
Relapse rate    High Low 
Extra-pancreatic lesions IgG4-related disease Inflammatory bowel disease 
 
Table 4: Discrimination between IAC, PSC and CC 
 IAC PSC CC 
Clinical features    
Age（years） 62.7 ± 10.7 42.4 ± 19.5   70.4 ± 11.7   
Gender  male  no differences no differences 
Presenting complaint or 
abnormality 
Obstructive 
jaundice 
Liver test abnormali-
ties 
Obstructive jaundice 
Association with AIP 74–96 % less frequently less  frequently 
Association with IBD less frequently   60 %-80 %   less frequently 
Serology    
IgG4 >135 mg/dl 83 %-100 %     5 %-9 %   22 % 
IgG >1800 mg/dl 67 %-93 % 58 %     17 % 
Tumor markers    
CA199 (U/ml) 101 ± 191    —     303 ± 524 
CEA (ng/dl) 3.3 ± 2.9        —     12.9 ± 42.0 
Clinical course no progressive progressive   progressive 
Steroid therapy responsive resistant resistant 
Treatment steroid therapy liver transplantation   hepatectomy 
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1. Association with autoimmune pan-
creatitis or other organ involvement 
2. Group A (include patients with a 
Type 1 cholangiogram): Ruling out pancre-
atic cancer with high serum level of IgG4; 
Group B (include those with Type 2): Rul-
ing out IBD with higher serum level of 
IgG4 or characteristic cholangiogram (dis-
criminant analysis) or liver biopsy; Group 
C (include those with Type 3 and Type 4): 
Ruling out cholangiocarcinoma and charac-
teristic IDUS (intraductal ultrasonography) 
findings [wall thickness (non-stricture) 
> 0.8 mm]  
3. Evident fibrosis and prominent infil-
tration of lymphocytes and IgG4-positive 
plasma cells were observed in the bile duct 
of biopsy specimen (Nakazawa et al., 
2012). 
 
Retroperitoneal fibrosis 
Retroperitoneal fibrosis (RF) is a chron-
ic inflammatory fibrosis condition. Many 
factors including infection, radiation thera-
py, drugs, malignant tumors, trauma, sur-
gery, and autoimmune lesions could result 
in retroperitoneal fibrosis (Stone, 2011). In 
this part we will discuss the autoimmune 
retroperitoneal fibrosis. In the last decade 
some cases of retroperitoneal fibrosis were 
intermittently reported in association with 
IgG4-related disease such as autoimmune 
pancreatitis, reticular lung lesion, periaorti-
tis in thoracic aorta. IgG4-related retroperi-
toneal fibrosis often primarily involved the 
abdominal aorta, the kidney, the urethra or 
no specific lesions with a mass of involve-
ment. The patients always have some atypi-
cal clinical pictures such as fever, low ab-
dominal pain, backache, lumbar pain or 
edema in lower extremities. In 2009, Zen 
selected 17 cases (10 cases of IgG4-related 
and 7 cases of non-IgG4-related) of retro-
peritoneal fibrosis to perform clinic patho-
logic analysis, and discovered the following 
characteristics of IgG4-related retroperito-
neal fibrosis. From the pathological speci-
mens, the number of IgG or IgG4-positive 
plasma cells, and the ratios of IgG4/IgG-
positive plasma cells in IgG4-related retro-
peritoneal fibrosis were significantly higher 
than that in Non-IgG4-related retroperito-
neal fibrosis cases. From the serological 
examinations, the concentration of IgG4 
and the IgG4/IgG ratio were significantly 
higher between the above two groups, but 
there were no significant differences in the 
IgG and antinuclear antibodies. IgG4-
related retroperitoneal fibrosis always in-
volves other organs or tissues, which in-
cludes pancreas, lung, sialaden and so on. 
Furthermore, the IgG4-related retroperito-
neal fibrosis responds well to steroid thera-
py and the prognosis is good (Zen et al., 
2009; van Bommel et al., 2009). However, 
there are no standard diagnostic criteria for 
retroperitoneal fibrosis until now. When we 
make a diagnosis, we should take the find-
ings of CT scanning and magnetic reso-
nance imaging, serological examination 
(essentially IgG4 should be greater than 
135 mg/dl) and other manifestations of 
IgG4-related disease into consideration. 
 
Other manifestations of IgG4-related  
disease 
Sclerosing cholangitis, sclerosing chol-
ecystitis, and retroperitoneal fibrosis are the 
peripancreatic inflammations in the abdo-
men. Besides these, there are other manifes-
tations of IgG4-related disease. When the 
lesion involves the salivary gland, it can 
cause Mikulicz’s disease (MD). MD is a 
part of IgG4-related disease, and the parotid 
gland involved either solely or along with 
the submandibular glands. MD was firstly 
reported by Johann von Mikulicz-Radecki 
in 1888. After that, MD was considered 
similar with SS (Sjogren’s syndrome) for 
many years, indeed MD was different from 
SS. The main differences of salivary gland 
in MD are listed as following: elevated se-
rum IgG4 concentrations and infiltration of 
plasmacytes expressing IgG4, the lack of 
anti-SS-A and anti-SS-B antibodies, good 
responsiveness to steroids, the persistent 
enlargement of lacrimal and salivary glands 
and not detectable or slight secretory dys-
function (Yamamoto et al., 2006). The 
IgG4-related interstitial lung disease can 
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present as interstitial lung disease (ILD), 
pulmonary inflammatory pseudotumor, and 
lymphomatoid granulomatosis (LYG). Zen 
et al. reported a case of IgG4-related pul-
monary inflammatory pseudotumor (Zen et 
al., 2005). Shigemitsu reported a case of 
IgG4-related ILD and reviewed related lit-
erature in 2009 (Shigemitsu et al., 2009). It 
more frequently affects males aged about 
60 years, sometimes with or without other 
organs involvement, into the lung of which 
were characterized by many IgG4-positive 
plasma cells infiltration, dense lympho-
plasmacytic infiltrates with fibrosis, eosin-
ophilic infiltration, and irregular narrowing 
of bronchioles. The chest X-ray and the 
chest CT may show diffuse ground-glass 
opacity, interlobular thickening, and bron-
chial wall thickening with hilar and medias-
tinal lymph-node swelling. And it also re-
sponds well to steroids (Shigemitsu et al., 
2009; Zen et al., 2005). 
 
CONCLUSION  
IgG4-related disease has been known 
for many years. However, its definite 
pathological mechanism is still unclear. 
Currently, IgG4-related disease has been 
recognized as an immunological process, 
but there was no specific antibody could be 
one marker for it, especially in pediatric 
cases. With the more cases of IgG4 related 
diseases have been identified in adult or 
pediatric patients (Mannion and Cron, 
2011), we believe people could discover the 
real entity of IgG4-related disease in the 
future.  
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